$206 billion State of Washington, et al. v. Philip Morris, et al.

Hagens Berman represented 13 states in the largest recovery in litigation history. Steve Berman served as special assistant attorney general for the states of Washington, Arizona, Illinois, Indiana, New York, Alaska, Idaho, Ohio, Oregon, Nevada, Montana, Vermont and Rhode Island in prosecuting major actions against the tobacco industry. more »

$27 billion Visa-Mastercard Antitrust Litigation

The firm served as co-lead counsel in what was then the largest antitrust settlement in history. The class-action lawsuit alleges that Visa and MasterCard, together with Bank of America, JP Morgan Chase and Wells Fargo, violated federal antitrust laws by establishing uniform agreements with U.S. banks that issue automated teller machine (ATM) cards. more »

$14.7 billion Volkswagen Emissions Litigation

Hagens Berman’s Steve Berman served as a court-appointed member of the Plaintiffs’ Steering Committee in the VW consumer litigation and part of the Settlement Negotiating team, and the firm was the first in the nation to file a lawsuit against Volkswagen for its emissions cheating. The settlement is the largest brought against an automaker. more »

$1.6 billion Toyota Motor Corp. Unintended Acceleration Litigation

Steve Berman was selected as class counsel on behalf of consumers for sudden unintended acceleration by the court, who selected him above any who submitted themselves for the role. Berman went on to settle the case which was at the time, the largest in history brought against an automaker. more »

$1.6 billion Volkswagen Franchise Dealers Litigation

The firm was named lead counsel representing VW franchise dealers in a class-action lawsuit in which a settlement has received final approval, and represents a result of nearly full damages for the class. The lawsuit states that in the midst of VW’s Dieselgate scandal, it withheld information about the scandal from dealers, even though it was aware of the issue since at least as early as 2014. more »

$1.45 billion Meracord

The firm’s team of attorneys secured a default judgment on behalf of consumers for useless debt-settlement conspiracy, following years of plaintiff victories in the case. Hagens Berman filed its lawsuit in 2011, on behalf of consumers nationwide, claiming the company violated Washington law and the federal Racketeer Influenced and Corrupt Organizations Act. more »

$700 million Washington Public Power Supply System Securities Litigation

Hagens Berman’s Steve Berman represented bondholders and the bondholder trustee in a class-action lawsuit stemming from the failure of two Washington Public Power Supply System (WPPSS) nuclear projects. After years of litigation, plaintiffs were awarded a $700 million settlement agreement brought against more than 200 defendants. more »

$560 million E-books Antitrust Litigation

The firm took on Apple and five of the nation's largest publishing companies in an antitrust class action regarding e-book price-fixing. When Apple’s portion – which was taken by the defendant to the Supreme Court, which sided with consumers – combined with prior settlements with the publisher defendants, consumers received more than twice the amount of losses suffered by consumers in a historic victory in consumer protection cases. more »

$470 million LCD Antitrust Litigation

Hagens Berman filed a class-action lawsuit against several major manufacturers of TFT LCD products claiming the companies engaged in a conspiracy to fix, raise, maintain and stabilize the price of TFT LCD products. After years of representing consumers against multiple defendants in multi-district litigation, the total settlements in the litigation exceeded $470 million. more »

$444 million McKesson Drug Litigation

Hagens Berman was lead counsel in these racketeering cases against McKesson for drug pricing fraud that settled on the eve of trials. The settlement involved the price of more than 400 prescription drugs, and more than 315,000 reimbursement checks were distributed by mail to eligible cash-payor consumer class members and “pharmacy” class members. more »

$383.5 million DaVita Dialysis Wrongful Death Cases 

Hagens Berman's expert trial attorneys recently won a monumental $383.5 million jury verdict on behalf of three families of dialysis patients who died after receiving treatment from DaVita. The verdict was the largest medical malpractice verdict in the country in 2018 according to the National Law Journal. more »

$345 million DRAM Antitrust Litigation

The firm was co-lead counsel in this class action claiming companies secretly agreed to reduce the supply of dynamic random access memory (DRAM) chips – $20 billion a year business – in order to artificially raise prices. The lawsuit settled in favor of purchasers of DRAM. more »

$338 million Average Wholesale Price Drug Litigation

Hagens Berman was co-lead counsel in this ground-breaking drug pricing case against the world’s largest pharmaceutical companies, resulting in a victory at trial. The class-action pharmaceutical fraud lawsuit asserted that the drug companies illegally inflated the prices which were then published in independent publications. The complaint alleged there was a conspiracy between the drug makers and pharmacy benefit managers. more »

$325 million Neurontin Pfizer Litigation

The firm brought suit against Pfizer and its subsidiary, Parke-Davis, accusing the companies of a fraudulent scheme to market and sell the drug Neurontin for a variety of "off-label" uses for which it is not approved or medically efficacious. The off-label promotion scheme remained hidden until a qui tam complaint filed by a previous Parke-Davis employee was fully unsealed. more »

$255 million Stericycle, Steri-Safe Litigation 

Hagens Berman represented small businesses including veterinary clinics, medical and dental clinics, and medical labs in a class-action lawsuit alleging Stericycle's billing practices and accounting software violated consumers laws and constituted breach of contract. more »

$255 million Hyundai & Kia Fuel Economy Litigation

Hagens Berman represented consumers in this class-action lawsuit, in which the court granted preliminary approval to the settlement potentially worth more than $255 million. The lawsuit accused Hyundai and Kia of knowingly selling vehicles whose EPA fuel economy ratings were less than stated. more »

$250 million Enron ERISA Litigation

Hagens Berman was co-lead counsel in this ERISA litigation which is the largest ERISA settlement in history. Attorneys representing 24,000 Enron employees against Enron and other parties claimed the company recklessly endangered their retirement funds, causing some employees to lose hundreds of thousands of dollars almost overnight. more »

$235 million Charles Schwab Securities Litigation

The firm was lead counsel in this action alleging fraud in the management of the Schwab YieldPlus mutual fund. The lawsuit claimed Charles Schwab and the funds' underwriter deceived investors about the underlying risk in the funds, which were sold as cash alternatives, but were in fact highly speculative and risky mortgage-related structured debt. more »

$215 million USC Sexual Harassment Litigation

Hagens Berman served as interim class counsel in this landmark sexual harassment class action in which a $215 million settlement was reached with the University of Southern California and its former full-time gynecologist, Dr. George Tyndall. Approximately 18,000 individuals are covered by the settlement. more »

$208 million NCAA Scholarship Cap Antitrust Litigation

The firm was lead counsel in this action claiming that the NCAA agreed in violation of national antitrust laws to unlawfully cap the value of athletic scholarships. The historic settlement will change the landscape of college sports and allow conferences to offer athletes additional benefits that the NCAA’s president has admitted are a benefit for student-athletes. more »

$200 million New England Compounding Pharmacy Meningitis Outbreak Litigation

Hagens Berman attorneys Thomas M. Sobol and Kristen A. Johnson serve as court-appointed lead counsel for the Plaintiffs’ Steering Committee on behalf of plaintiff-victims of the 2012 fungal meningitis outbreak. The Center for Disease Control (CDC) confirmed that NECC sold at least 17,000 potentially tainted steroid shots to 75 clinics in 23 states across the country, resulting in more than 64 deaths and 751 cases of fungal meningitis, stroke, or paraspinal/peripheral joint infection. more »

$169 million Animation Workers Antitrust Litigation

As court-appointed co-lead counsel, Hagens Berman helped finalize settlement agreements totaling $169 million involving multiple major players in the entertainment industry, including BlueSky, Sony, DreamWorks and Disney. The firm represented a nationwide class of approximately 10,000 animators and other artistic workers in this antitrust class-action case. more »

$150 million Lupron Consumer Litigation

Hagens Berman secured a settlement against TAP Pharmaceuticals Products Inc. on behalf of patients using Lupron for prostate cancer. The lawsuit states that TAP and Takeda Pharmaceutical Company Limited conspired to fraudulently market, sell and distribute Lupron, causing consumers to pay inflated prices for the drug Lupron. more »

$150 million Flonase Antitrust Litigation

Hagens Berman served as court-appointed co-lead class counsel of a class of direct purchasers alleging that GlaxoSmithKline intentionally submitted a sham citizen petitions to the U.S. Food and Drug Administration, and actually delayed the approval of generic versions of Flonase. more »

$123.4 million Expedia Hotel Taxes and Fees Litigation

Hagens Berman obtained summary judgment in this class action to recover deceptive service fees and settled the case. The lawsuit filed in 2005 on behalf of consumers claimed the travel-booking giant defrauded consumers by repeatedly breaching its contractual obligations and charging service fees under false pretenses in millions of hotel transactions. more »

$100 million Oppenheimer Core Bond and Champion Income Funds Litigation

Hagens Berman obtained these combined settlements in two case alleging that various Oppenheimer entities and certain individual defendants made materially false or misleading statements and omissions to the investing public regarding the investment profile and objectives of the two funds. more »

$100 million Tremont Group Holdings Litigation

The court appointed Hagens Berman co-lead counsel in this class-action lawsuit on behalf of investors and groups that invested capital with Tremont Group Holdings. The suit alleges investors lost a total of $3.3 billion in assets, $3.1 billion from the Rye Funds. The lawsuit alleges the company and others grossly neglected fiduciary duties by turning capital over to Bernard Madoff Investment Securities. more »

$98 million Prograf Antitrust Litigation

Hagens Berman served as court-appointed co-lead class counsel representing a class of direct purchasers of Prograf. The antitrust lawsuit alleges that Astellas violated antitrust laws by filing petition with the FDA as a means of delaying entry of a generic version of Prograf, a drug used to prevent organ rejection by kidney, liver, heart and lung transplant patients. more »

$92.5 million Boeing Securities Litigation

Boeing and Hagens Berman agreed to a proposed settlement to this shareholder suit filed in November 1997 by Hagens Berman. The settlement, the then second largest awarded in the Northwest, affected tens of thousands of Boeing common stock shareholders. more »